| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 奥美拉唑碳酸氢钠干混悬剂(I)(元) | 1,380,195.63 | 3,485,765.54 | 1,726,582.38 |
| 龙芪溶栓肠溶胶囊(元) | - | 19,397,336.28 | 12,201,115.04 |
| 龙心口服液(元) | 3,886,429.42 | 8,185,624.93 | 4,194,632.93 |
| 芪龙胶囊(元) | 16,574,294.16 | 76,661,949.45 | 48,330,212.39 |
| 龙芪胶囊(元) | 13,277,401.78 | - | - |
| 其他(元) | 7,572,112.88 | 10,124,309.06 | 3,788,425.07 |
| 营业成本(元) | |||
| 奥美拉唑碳酸氢钠干混悬剂(I)(元) | 1,672,089.25 | 3,570,108.86 | 1,780,927.23 |
| 龙芪溶栓肠溶胶囊(元) | - | 8,866,918.20 | 6,117,736.81 |
| 龙心口服液(元) | 2,359,627.63 | 5,683,848.61 | 3,148,438.40 |
| 芪龙胶囊(元) | 7,270,711.44 | 13,684,125.62 | 7,617,973.23 |
| 龙芪胶囊(元) | 7,653,395.85 | - | - |
| 其他(元) | 6,657,210.62 | 11,464,021.02 | 3,928,416.72 |
| 毛利(元) | |||
| 奥美拉唑碳酸氢钠干混悬剂(I)(元) | -291,893.62 | -84,343.32 | -54,344.85 |
| 龙芪溶栓肠溶胶囊(元) | - | 10,530,418.08 | 6,083,378.23 |
| 龙心口服液(元) | 1,526,801.79 | 2,501,776.32 | 1,046,194.53 |
| 芪龙胶囊(元) | 9,303,582.72 | 62,977,823.83 | 40,712,239.16 |
| 龙芪胶囊(元) | 5,624,005.93 | - | - |
| 其他(元) | 914,902.26 | -1,339,711.96 | -139,991.65 |
| 毛利率(%) | |||
| 奥美拉唑碳酸氢钠干混悬剂(I)(%) | -21.15 | -2.42 | -3.15 |
| 龙芪溶栓肠溶胶囊(%) | - | 54.29 | 49.86 |
| 龙心口服液(%) | 39.29 | 30.56 | 24.94 |
| 芪龙胶囊(%) | 56.13 | 82.15 | 84.24 |
| 龙芪胶囊(%) | 42.36 | - | - |
| 其他(%) | 12.08 | -13.23 | -3.70 |
| 收入构成(%) | |||
| 奥美拉唑碳酸氢钠干混悬剂(I)(%) | 3.23 | 2.96 | 2.46 |
| 龙芪溶栓肠溶胶囊(%) | - | 16.46 | 17.37 |
| 龙心口服液(%) | 9.10 | 6.95 | 5.97 |
| 芪龙胶囊(%) | 38.82 | 65.05 | 68.81 |
| 龙芪胶囊(%) | 31.10 | - | - |
| 其他(%) | 17.74 | 8.59 | 5.39 |
| 毛利构成(%) | |||
| 奥美拉唑碳酸氢钠干混悬剂(I)(%) | -1.71 | -0.11 | -0.11 |
| 龙芪溶栓肠溶胶囊(%) | - | 14.12 | 12.77 |
| 龙心口服液(%) | 8.94 | 3.35 | 2.20 |
| 芪龙胶囊(%) | 54.48 | 84.44 | 85.44 |
| 龙芪胶囊(%) | 32.93 | - | - |
| 其他(%) | 5.36 | -1.80 | -0.29 |